Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
COSMOS PharmaceuticalCSMYF 93 Forward Dividend Yield % is 1.27% as of Jul. 14, 2026. GuruFocus rates CSMYF with a GF Score™ of 93/100 and a GF Value™ of $50.48 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 275 Healthcare Providers & Services companies, COSMOS Pharmaceutical ranks worse than 76.36% on this metric.
As of today (2026-07-14), the Forward Annual Dividend Yield of COSMOS Pharmaceutical is 1.27%.
As of today (2026-07-14), the Trailing Annual Dividend Yield of COSMOS Pharmaceutical is 1.29%.
CSMYF's Forward Dividend Yield % is ranked worse than 76.36% of 275
companies
in the Healthcare Providers & Services industry
Industry Median: 2.51
vs CSMYF: 1.27
During the past 12 months, COSMOS Pharmaceutical's average Dividends Per Share Growth Rate was 20.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 20.50% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 23.00% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 16.60% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of COSMOS Pharmaceutical was 51.80% per year. The lowest was 6.90% per year. And the median was 15.85% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
COSMOS Pharmaceutical Forward Dividend Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where COSMOS Pharmaceutical's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
COSMOS Pharmaceutical Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
JPY 44.500000
2026-05-28
2026-05-31
2026-08-10
Cash Dividend
semi-annually
JPY:USD 0.006280
JPY 37.500000
2025-11-28
2025-11-30
2026-02-12
Cash Dividend
semi-annually
JPY:USD 0.006401
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
COSMOS Pharmaceutical's Forward Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 1.27% mean?
COSMOS Pharmaceutical (CSMYF) has a Forward Dividend Yield % of 1.27% as of Jul. 14, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on COSMOS Pharmaceutical and its competitors. According to the industry distribution chart, COSMOS Pharmaceutical ranks #210 out of 275 companies in the Healthcare Providers & Services industry, placing it in the top 76.4%.
Is COSMOS Pharmaceutical's Forward Dividend Yield % too high?
COSMOS Pharmaceutical's current Forward Dividend Yield % is 1.27%. The Healthcare Providers & Services industry median Forward Dividend Yield % is 2.51. COSMOS Pharmaceutical's value of 1.27% is 49.4% below this industry median. Based on the distribution chart, COSMOS Pharmaceutical ranks #210 out of 275 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, COSMOS Pharmaceutical has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does COSMOS Pharmaceutical's Forward Dividend Yield % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, COSMOS Pharmaceutical ranks #210 out of 275 companies for Forward Dividend Yield %. This places COSMOS Pharmaceutical in the lower half of its industry. The industry median Forward Dividend Yield % is 2.51. COSMOS Pharmaceutical's value of 1.27% is 49.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Healthcare Providers & Services company?
The median Forward Dividend Yield % among Healthcare Providers & Services companies is 2.51, based on 275 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. COSMOS Pharmaceutical's current Forward Dividend Yield % of 1.27% is 49.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on COSMOS Pharmaceutical and its competitors. For the Healthcare Providers & Services industry, the median Forward Dividend Yield % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. COSMOS Pharmaceutical's current Forward Dividend Yield % is 1.27%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is COSMOS Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, COSMOS Pharmaceutical (CSMYF) is currently considered Modestly Undervalued. The stock's GF Value™ is $50.48, compared to a current price of $37.06 — trading 26.6% below its estimated fair value. The current Forward Dividend Yield % is 1.27% and 49.4% below the Healthcare Providers & Services industry median of 2.51. COSMOS Pharmaceutical's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For COSMOS Pharmaceutical (CSMYF), the current Forward Dividend Yield % is 1.27% as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is COSMOS Pharmaceutical (CSMYF) Overvalued in 2026?
Based on GuruFocus' analysis, COSMOS Pharmaceutical stock appears to be undervalued.
The current stock price of $37.06 is trading 26.6% below its estimated GF Value™ of $50.48.
GuruFocus considers COSMOS Pharmaceutical to be Modestly Undervalued.
Key valuation signals for CSMYF:
Forward Dividend Yield %: 1.27%
GF Value™: $50.48 vs. price of $37.06 (26.6% below fair value)
Industry Position: 49.4% below the Healthcare Providers & Services median (#210 of 275)
No single metric tells the full story. See the CSMYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company emphasizes convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. It also operates a private grocery brand called ON 365.
93GF Score
Get the complete analysis for CSMYF
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSMYF has been successfully added to your 
